• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Analysts are bullish on Align Technology

Analysts are bullish on Align Technology

April 15, 2021 By Sean Whooley

Align TechnologyAnalysts are bullish on Align Technology (NSDQ:ALGN) after the company has seemingly prospered despite the COVID-19 pandemic.

SVB Leerink senior research analyst Richard Newitter explained in an analysis that Align, a maker of clear teeth aligners, is a “unique-in-healthcare” growth asset with an underpenetrated total available market (TAM).

Analysts see the company as a relatively less expensive way to invest in high-growth medtech stock when compared to peers, particularly as the clear aligner space benefits from an accelerating adoption curve that got a major boost from the pandemic.

Align Technology saw increased demand for its clear teeth aligners throughout 2020 as people tended to be more reluctant to go to an orthodontist’s office to get traditional wire teeth braces adjusted. The San Jose, Calif.–based company registered $2.5 billion in sales in 2020, notching 2.7% growth from 2019 when the company earned $2.4 billion in sales. In a pre-pandemic scape, the company grew 22.4% from 2018 to 2019.

Newitter and the analysts expect a strong first quarter of 2021 from the company, with revenues and earnings expected to beat Wall Street projections.

A “COVID-19 hangover” is not expected by the analysts, while what they dubbed the “Zoom effect” brought on by the pandemic is increasing patients’ awareness of physical appearance because they’re viewing themself on a screen.

On top of that, the analysts found that consumers see Align’s Invisalign clear aligners as the best option on the market, with the general view from users insinuating that price discounts from others solutions would need to be bigger to incentivize a switch away from the market-leading option for pricing purposes only.

The analysts have increased their 2021-2022 revenue estimates for Align due to the strong performance and potential down the line.

Filed Under: Business/Financial News, Dental, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Align Technology, coronavirus, COVID-19

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy